pharmaphorum March 24, 2025
US DNA testing specialist 23andMe has filed for bankruptcy, prompting the resignation of co-founder and chief executive Anne Wojcicki with immediate effect.
The Silicon Valley company said the Chapter 11 filing aims to “facilitate a sale process to maximise the value of its business” and it will continue to operate as normal while the process plays out. It also stressed that there will be “no changes to the way the company stores, manages, or protects customer data.”
23andMe said it was looking to sell the business in January, a few weeks after announcing job losses that cut its headcount by around 40% and an exit from drug discovery and development operations as it tried to slice $35 million off its...
Today's Sponsors
Today's Sponsor